Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Every peptide we produce is verified through HPLC and mass spectrometry, with a Certificate of Analysis behind every batch
January 26, 2022
Peggion C, Panetta V, Lastella L, Formaggio F, Ricci A, Oancea S, et al
Peptides are commonly taken daily, similar to vitamins and supplements, but some may be administered weekly
D., & Thalib, L
After decades with no disease-modifying drug, 20242026 finally delivered the first targeted therapies: Novartis ianalumab met both NEPTUNUS-1 & NEPTUNUS-2 Phase 3 endpoints and won FDA Breakthrough Therapy status in Jan 2026, and J&Js nipocalimab was positive in the Phase 2 DAHLIAS trial ( The Lancet )
US$ 27.89
US$ 23.73
US$ 29.18
US$ 24.20
US$ 20.61
US$ 23.21
US$ 27.18
US$ 25.28
